to promote heart healing after myocardial infarction (MI). Furthermore, in
vitro and in vivo studies
Кондратенко, Р.М.,
Балтина, Л.А.,
Mustafina, S.R.,
Makarova, N.V.,
Насыров, Х.М.,
Толстиков, Г.А.,
Kondratenko, R.M.,
Baltina, L.A.,
Nasyrov, Kh.M.,
Tolstikov ,G.A. (2001)
of -interferon both in
vitro and in vivo [5, 6]. It was also reported
that GA and its derivatives are capable
Chu, Q.,
Jiang, Y.,
Zhang, W.,
Xu, C.,
Du, W.,
Tuguzbaeva, G.,
Qin, Y.,
Li, A.,
Zhang, L.,
Sun, G.,
Cai, Y.,
Feng, Q.,
Li, G.,
Li, Y.,
Yang, B. (2016) both in
vitro and in vivo, which was attenuated by caspase-1 inhibitor Ac-YVAD-CMK. Conclusively
Tsypysheva, I.P.,
Kovalskaya, A.V.,
Lobov, A.N.,
Makara, N.S.,
Petrova, P.R.,
Farafontova, E.I.,
Zainullina, L.F.,
Vakhitova, Yu.V.,
Zarudii, F.S. (2015) and antihypoxic properties) and in
vitro (antiradical properties and ability to affect transcription factor HIF-1
is performed according to the “guidance on preclinical
research of new pharmacological substances” in
vitroDzhemilev, Usein M.,
D’yakonov, Vladimir A.,
Tuktarova, Regina A.,
Dzhemileva, Lilya U.,
Ishmukhametova, Svetlana R.,
Yunusbaeva, Milyausha M.,
Armin de Meijere (2016) . It has been demonstrated for the first time that muricadienin exhibits a moderate in
vitro inhibitory
Ligacheva, A.A.,
Sherstoboev, E.Y.,
Danilets, M.G.,
Trofimova, E.S.,
Krivoshchekov, S.V.,
Khasanova, S.R.,
Kudashkina, N.V.,
Gur’ev, A.M.,
Belousov, M.V. (2021) The in
vitro addition of water-soluble polysaccharides isolated from the leaves of Crataegus
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) of glioblastoma. However, clinical trials are still needed to confirm the properties of these compounds in
vitro